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Abstract
Objectives: To systematically summarize the randomized trial evidence regarding the relative effectiveness of cognitive
behavioural therapy (CBT) in patients with depression in receipt of disability benefits in comparison to those not receiving
disability benefits.
Data Sources: All relevant RCTs from a database of randomized controlled and comparative studies examining the effects of
psychotherapy for adult depression (http://www.evidencebasedpsychotherapies.org), electronic databases (MEDLINE,
EMBASE, PSYCINFO, AMED, CINAHL and CENTRAL) to June 2011, and bibliographies of all relevant articles.
Study Eligibility Criteria, Participants and Intervention: Adult patients with major depression, randomly assigned to CBT
versus minimal/no treatment or care-as-usual.
Study Appraisal and Synthesis Methods: Three teams of reviewers, independently and in duplicate, completed title and
abstract screening, full text review and data extraction. We performed an individual patient data meta-analysis to
summarize data.
Results: Of 92 eligible trials, 70 provided author contact information; of these 56 (80%) were successfully contacted to
establish if they captured receipt of benefits as a baseline characteristic; 8 recorded benefit status, and 3 enrolled some
patients in receipt of benefits, of which 2 provided individual patient data. Including both patients receiving and not
receiving disability benefits, 2 trials (227 patients) suggested a possible reduction in depression with CBT, as measured by
the Beck Depression Inventory, mean difference [MD] (95% confidence interval [CI]) =22.61 (25.28, 0.07), p = 0.06;
minimally important difference of 5. The effect appeared larger, though not significantly, in those in receipt of benefits (34
patients) versus not receiving benefits (193 patients); MD (95% CI) =24.46 (212.21, 3.30), p = 0.26.
Conclusions: Our data does not support the hypothesis that CBT has smaller effects in depressed patients receiving
disability benefits versus other patients. Given that the confidence interval is wide, a decreased effect is still possible,
though if the difference exists, it is likely to be small.
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Introduction
Major Depressive Disorder (henceforth referred to as depres-
sion) results in immense human suffering and an enormous
socioeconomic burden. Depression accounts for 11% of disability
worldwide and an estimated productivity loss of $17 to $44 billion
in the USA [1,2]. Depression is expected to become the second
leading cause of disease burden worldwide by the year 2020 [3].
The National Institute for Health and Clinical Excellence
(NICE) in the UK recommends that health care professionals
provide pharmacological treatments and/or high-intensity psy-
chological interventions for individuals suffering from depression.
Pharmacological treatments may accelerate recovery from depres-
sion, particularly when symptoms are severe [4] and, over the last
few decades, their use has increased dramatically in Western
nations [5,6]. NICE guidelines suggest psychological therapies
should be offered to individuals suffering from persistent
subthreshold symptoms of depression, mild to moderate depres-
sion, and those with a high risk of relapse or those declining
pharmacological treatment for severe depression [5,6].
Cognitive Behavioral Therapy (CBT) is a common non-
pharmacological treatment for depression [5,7]. CBT is based
on three fundamental propositions: cognitive activity affects
behavior, cognitive activity can be monitored and altered, and
desired behavior change may be affected through cognitive change
[7]. Twelve systematic reviews evaluating CBT in individuals
suffering from depression have demonstrated that CBT reduces
depressive symptoms [8,9,10,11,12,13,14,15,16,17,18,19], with
the most current and rigorous meta-analysis reporting a pooled
standardized mean difference (SMD) of 0.69 (95% confidence
interval [CI] of 0.59 to 0.79) [13].
In North America, depression is one of the most frequent
reasons for receiving disability benefits [20,21], and disability
claims for mental health disorders incur greater costs compared to
other disorders [22]. In those receiving disability benefits,
individuals suffering from mental health disorders require more
treatment and have greater difficulty returning to work than those
suffering from other conditions [23]. Although CBT is one of the
most frequently reimbursed therapies by insurers, its utilization by
insurance companies still remains relatively low at approximately
3% for short-term disability claimants and 15% for long-term
disability claimants [24].
CBT may be less effective, or ineffective, in patients receiving
disability benefits, because their circumstances or psychological
status may interfere with its successful implementation [25]. This
may also be associated with the compensation process [26],
secondary gain from financial benefits (benefits of assuming a sick
role) [27], or the adversarial nature of litigation [28]. A recent
meta-analysis of 129 studies in surgical populations that found a
substantially greater risk of an unsatisfactory outcome (functional,
quality of life, pain and patient satisfaction) after surgery in
compensated patients (odds ratio [95% CI] = 3.79 [3.28 to 4.37])
provides indirect evidence for this hypothesis [29]. The effective-
ness of CBT for depression in patients receiving disability benefits
has received little attention.
Objectives
The purpose of our study was to perform a systematic review
and an individual patient data meta-analysis of all randomized
controlled trials (RCTs) that compared the effectiveness of CBT to
minimal/no treatment, or care-as-usual, in patients with depres-
sion receiving versus those not receiving disability benefits.
Questions
In adult patients with depression, is there a difference in the
effect of CBT on depression between those receiving disability
benefits compared those not receiving disability benefits?
Methods
We used the PRISMA guidelines [30] to report our findings.
Protocol and registration
We developed a protocol prior to conducting the study but did
not register it.
Eligibility criteria
Eligible studies met the following criteria: 1) random allocation
of adult patients to CBT or a control arm consisting of minimal/
no treatment, treatment as usual (TAU) or pharmacotherapy if it
was equally balanced in the treatment groups (e.g. CBT plus
pharmacotherapy versus pharmacotherapy alone), and 2) inclusion
of patients with depression, classified as Major Depressive
Disorder by any edition of the Diagnostic and Statistical Manual
(DSM), International Classification of Diseases (ICD), Research
Diagnostic Criteria (RDC) or other diagnostic system [31].
Information sources
We identified all relevant RCTs from a database of randomized
controlled trials and comparative studies examining the effects of
psychotherapy for adult depression (http://www.
evidencebasedpsychotherapies.org) [32]. This database consisted
of 281 trials and was identified from searching the following
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electronic databases in all languages: PUBMED, EMBASE,
PsycINFO and Cochrane Central Register of Controlled Trials,
from inception until January 1, 2011 [11]. In addition to the 281
trials, we updated the search with the assistance of an experienced
academic librarian (RC) until June 13, 2011 for each electronic
database, and also searched AMED and CINAHL. We hand
searched the reference lists of all relevant RCTs for additional
eligible trials.
Search
Our search strategy including keywords and MESH headings
are provided in Appendix A.
Study selection
Three teams of reviewers (SE, SH, LM, WT, MK, ACL) worked
in pairs and screened titles and abstracts of identified citations,
independently and in duplicate, using a standardized, pilot-tested
screening form. The same reviewers independently applied
eligibility criteria to the full text of potentially eligible studies. One
psychiatrist (IPS) and one psychologist (RM), blinded to study
results, independently reviewed and confirmed eligibility of
therapies that were not explicitly described by trial authors as
CBT. We measured agreement for the full text review stage, and
interpreted the agreement statistics using the guidelines proposed by
Landis and Koch [33]. Kappa values of 0 to 0.20 represented slight
agreement, 0.21 to 0.40 fair agreement, 0.41 to 0.60 moderate
agreement, 0.61 to 0.80 substantial agreement, and greater than
0.80 almost perfect agreement.
Reviewers grouped eligible articles into one of the four categories:
(i) studies that did not explicitly state if they included or excluded
patients receiving disability benefits, (ii) studies that explicitly
excluded patients receiving disability benefits, (iii) studies that
explicitly included patients receiving disability benefits but did not
separately report outcomes based on receipt of disability benefits,
and (iv) studies that explicitly included patients receiving disability
benefits and reported outcomes separately based on receipt of
disability benefits. Disability benefits were defined as wage
replacement benefits administered by a third party (e.g. insurer).
Contacting authors of eligible studies
We identified 88 studies in category i, 4 in category iii, and none
in either category ii or iv. Contact information was not reported
and not available through an Internet search for authors of 22
(24%) trials. We attempted to contact authors of the remaining 70
trials by email and requested information on whether they had an
eligibility stipulation for disability status. If authors included
patients on disability benefits, we requested their trial data to
facilitate an individual patient data meta-analysis (IPDMA). To
maintain patient confidentiality, authors removed any personal
identifiers from their dataset prior to transferring it to our center.
We clarified uncertainties or discrepancies in the data sets with the
study authors and combined individual patient data for variables
that were similar across the trials. Based on authors’ replies, we
classified studies into four groups: (A) those that did have some
data specific to patients on disability benefits, (B) those that
confirmed that they had no patients on disability benefits, (C) those
that did not have an eligibility criterion for disability status and did
not collect information on disability status, and (D) unknown or
did not respond.
Data collection process
Using piloted standardized forms and a detailed instruction
manual to extract data, the same teams of reviewers extracted
data, independently and in duplicate, from studies in groups A and
B. We did not abstract data from groups C and D.
Data abstracted included patient characteristics, treatment
effect on depression, frequency and timing of follow-up, details
of depression (including diagnostic classification system used,
severity of depression, and duration of depression), and CBT
intervention details (including the type of CBT administered,
expertise of providers administering CBT, and frequency of CBT).
Reviewers abstracted data from the following study arms: CBT,
TAU and minimal or no treatment. Data comparing CBT only to
active comparators were not abstracted, unless the active
comparator was equally balanced between both the treatment
and control group.
Risk of Bias in individual studies
Using a modified Cochrane risk of bias instrument, reviewers
assessed risk of bias for each eligible trial on the following domains:
sequence generation; allocation concealment; blinding of partic-
ipants, investigators, data collectors, outcome assessors, and data
analysts; incomplete outcome data; selective outcome reporting;
and other sources of bias (e.g. bias of study design, trial stopped
early, extreme baseline imbalance, and fraudulent trial) [34,35].
Reviewers used response options of ‘‘definitely yes’’, ‘‘probably
yes’’, ‘‘probably no’’, and ‘‘definitely no’’ with definitely and
probably yes ultimately assigned high risk of bias and probably and
definitely no assigned low risk of bias [35]. The reviewers resolved
disagreements by discussion, and an arbitrator (JWB) adjudicated
any remaining conflicts.
Synthesis of results
For our IPDMA, we compared the effects (mean difference) of
CBT on depression, measured by the most commonly reported
instrument [Beck Depression Inventory (BDI–II)], in patients
receiving disability benefits versus patients not receiving disability
benefits. We used a one-stage method [36], and included the
following variables in our model: study arm, receipt of disability
benefits, interaction term of study arm and receipt of disability
benefits, trial as a categorical variable, age and baseline BDI–II
score. To guard against multiplicity of data [37], we used the most
common follow-up time point of 3 months for our analysis.
Our secondary analyses evaluated whether there were differ-
ences in patients not in receipt of disability benefits between trials
that included patients in receipt of disability benefits (group A) and
trials with aggregate data that did not include patients receiving
disability benefits (group B). We compared the following: 1) the
effects of CBT between group A and B; 2) the effects of CBT
between group A and B that compared CBT plus pharmacother-
apy versus pharmacotherapy alone; 3) the effects of CBT between
group A and B that compared CBT to TAU.
For our secondary analyses, we used the 2-stage method [38]. In
the first stage, we aggregated the IPD data of the patients not
receiving disability benefits in group A and in the second stage,
pooled the aggregate data of studies in group A and B using a
random-effects model.
We used the means and standard deviations (SDs) of the end of
study scores for our secondary pooled analyses. To pool data
across trials and to facilitate interpretation for clinicians and other
stakeholders, we calculated the mean difference (MD) and its
associated 95% confidence interval (CI) of the natural units of the
most familiar instrument across trials, the BDI–II. For this
calculation, we used the following formulas to convert mean
estimates (M) and standard deviations (SD) into the scale of the
most familiar instrument: MA= (MB - LB) (RA/RB)+LA and
SDA=SDB (RA/RB)+LA, where A represented the most familiar
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instrument and B represented the alternative instrument, LA and
LB represent the lower range of instrument A and B respectively,
and RA and RB represented the ranges for instruments A and B
respectively [39].
We examined heterogeneity using both a chi-squared test and
the I2 statistic [40]. Heterogeneity defined by an I2 of 0% to 40%
was interpreted as ‘might not be important’, 30% to 60% as
‘moderate heterogeneity’, 50% to 90% as ‘substantial heteroge-
neity’, and 75% to 100% as ‘considerable heterogeneity’ [40]. We
generated the following a priori hypotheses to explain variability
between studies in our secondary analyses: studies using in-person
CBT will have greater effects than studies using computer
administered-CBT, and studies with high risk of bias will
demonstrate larger effects compared to studies with low risk of
bias.
We performed analyses using SPSS version 20 and the
Cochrane Collaboration Review Manager software (RevMan
version 5.1.2).
Results
Study selection
We screened 977 citations and retrieved 421 articles in full text;
329 studies did not meet inclusion criteria and 92 trials were
deemed eligible. The kappa (95% CI) chance-corrected agreement
on assessing full text eligibility was 0.74 (0.66 to 0.81), representing
substantial agreement.
After establishing author contact for 56 of the 70 trials for which
we acquired contact information, we found that 45 trials did not
have an eligibility criterion based on disability benefit status or
collect information on disability status, 6 trials did not enrol any
patients in receipt of disability benefits, and 5 trials enrolled some
patients in receipt of disability benefits. Authors of 4 of the 5 trials
that included patients in receipt of disability benefits agreed to
provide individual patient data. Two of these trials combined
patients who were disabled with unemployed and retired
individuals and information specific to receipt of disability benefits
were uncertain; these trials were therefore excluded from our
IPDMA. Our primary analysis consisted of the 2 remaining trials
that included some patients in receipt of disability benefits [41,42],
and our secondary analyses consisted of 8 trials, i.e., 6 trials that
did not enrol any patients in receipt of disability benefits
[43,44,45,46,47,48], and 2 trials that included some patients in
receipt of disability benefits (Figure 1) [41,42].
Study characteristics
Seven studies were parallel group RCTs
[41,42,43,44,45,46,47], and one was a cluster RCT [48]. Table 1
describes the characteristics of the 8 eligible trials, and Table 2
provides details regarding their interventions.
Figure 1. Flow chart of study eligibility.
doi:10.1371/journal.pone.0050202.g001
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Risk of bias within studies
Protection against bias was generally poor (Figure 2). All 8 trials
reported loss to follow-up (LTFU), ranging from 4% to 40%. Four
trials excluded those LTFU and performed a complete case
analysis [41,42,43,48], 2 used the last observation carried forward
[44,46], 1 used multiple imputation (56), and 1 did not report an
approach [47].
IPDMA
Two trials including data on patients receiving disability benefits
enrolled a total of 227 patients; 34 in receipt of disability benefits
and 193 not receiving disability benefits. The mean (SD) baseline
BDI–II score for patients with disability benefits was 32.9 (68.55)
and for patients not receiving disability benefits 26.9 (67.9).
Pooled results from these 2 trials, including both those receiving
and not receiving disability benefits, suggested a possible benefit of
CBT on depression (MD=22.61; 95% CI=25.28 to 0.07;
p = 0.06, minimally important difference [MID]= 5), as did results
from both the subgroup of patients in receipt of disability benefits
(MD=26.88; 95% CI=214.06 to 0.31), and patients not
receiving disability benefits (MD=22.22; 95% CI=25.07 to
0.63). Results suggested a possible larger effect on reducing
depression in those receiving versus not receiving disability
benefits, though the confidence interval includes a small reduction
in benefit in those receiving benefits (MD=24.46; 95%
CI=212.21 to 3.30; p = 0.26; MID=5).
Secondary analyses
There were no significant differences in the effect of CBT on
depression among patients not in receipt of disability benefits
across studies that enrolled patients receiving disability benefits
and studies that did not (p = 0.26) (Figure S1). There were no
significant differences in the effect of CBT on depression within
patients not receiving disability benefits in studies comparing CBT
Table 2. CBT details from studies.
Study
Mode of administration
of CBT
Duration of CBT
per visit
Frequency
of CBT
Total
duration
of CBT
Clinical background
of the individuals
administering CBT
Was there a
standardized
program or
certification process
that CBT providers
have undergone or
had to undergo?
De Graaf 2009 [41] Computer/internet based CBT 30 minutes 1 per week 9 weeks Not reported Not reported
Dozois 2009 [42] In-person individualized CBT 1 hour 1 per week 15 weeks Master’s level therapist Not reported
Naeem 2011 [47] In-person individualized CBT Not reported 1 to 2 sessions
per week
9 weeks Psychiatrist; psychology
graduates
Not reported
Faramarzi 2007 [43] In-person group CBT 2 hours 1 per week 10 weeks Psychologist Not reported
Hollon 1992 [44] In-person individualized CBT 50 minutes 2 in the first 4
weeks, 1 or 2
in the next 4
weeks, and 1
in the last weeks
12 weeks Psychologist;
social worker
Not reported
Miranda 2003 [45] In-person individualized CBT Not reported 1 per week 8 weeks Psychologist;
psychotherapist
Not reported
Misri 2004 [46] In-person individualized CBT 1 hour 1 per week 12 weeks Psychologist Not reported
Rahman 2008 [48] In-person individualized CBT Not reported 4 in 1st month,
3 in 2nd month,
and 1 per month
for next 9 months
11 weeks Lady health workers Not reported
CBT –Cognitive Behavioural Therapy.
doi:10.1371/journal.pone.0050202.t002
Figure 2. Risk of Bias within studies. ‘+’ denotes low risk of bias,
and ‘2’ represents high risk of bias.
doi:10.1371/journal.pone.0050202.g002
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plus pharmacotherapy versus pharmacotherapy alone (p= 0.94)
(Figure S2). There were no significant differences in the effect of
CBT on depression within patients not receiving disability benefits
in studies comparing CBT versus TAU/standard care (p = 0.59)
(Figure S3). Our a priori subgroup hypotheses failed to explain the
heterogeneity observed in our secondary analyses.
Discussion
Summary of evidence
This is the first systematic review comparing the effect of
receiving disability benefits on depression following treatment with
CBT. We failed to find differences in the effect of CBT on
depression between patients receiving disability benefits and
patients not receiving disability benefits. The results suggest a
possible greater effect in those receiving disability benefits (24.46
BDI units in which the minimally important difference is 5), and
the boundaries of the confidence interval suggest that if there is a
decrement in benefit, that decrement is small (no greater than 3.30
BDI–II units). Nevertheless, these data come from only 34 patients
receiving disability benefits, so that any inferences regarding
relative effect in the two populations are very weak.
The strengths of our review include a comprehensive and
transparent search strategy, independent and duplicate eligibility
assessment, use of the most commonly reported instrument with
the most established reliability and validity (BDI–II) for our pooled
analysis, and use of individual patient data from eligible trials,
allowing adjustment for potential confounding predictors. We also
ensured rigorous data abstraction by using detailed written
instructions, conducting formal calibration exercises, conducting
in duplicate, and implementing a consensus approach to resolve
disagreement. We contacted authors to verify whether they
enrolled patients in receipt of disability benefits and achieved an
80% response rate among trials for which we were able to acquire
author contact information.
Although no prior reviews have explored the effect of CBT in
patients receiving disability benefits, reviews have explored the
effect of compensation in other patient populations. A 2005
systematic review found that the presence of compensation was
associated with worse outcome (combination of functional, quality
of life, pain and patient satisfaction outcome that was rated as
satisfactory or unsatisfactory by review investigators) after surgery
[29]. This was consistent with findings from systematic reviews
regarding chronic pain and closed-head injuries [49,50], which
reported a significant effect between compensation and poor
outcome. This indirect evidence, however, does not address the
relative effect of interventions in the populations (one may have
poorer outcomes, but still have larger treatment effects if results
without treatment are very poor). In the two trials we examined,
patients in receipt of disability benefits had a greater severity of
depression than those who were not receiving disability benefits
(baseline BDI–II of 32.9 versus 26.9). Although a prior review
reported that the effectiveness of CBT was reduced in patients
with severe depression compared to those with mild to moderate
depression [51], we found no suggestion of a smaller effect of CBT
in patients receiving disability benefits.
Limitations
Our study has limitations. First, our IPDMA is based on only 34
patients in receipt of disability benefits and 193 patients not
receiving disability benefits. The extent to which findings from this
small sample will generalize to a wide population of individuals in
receipt of benefits is uncertain. Second, our secondary analyses
showed substantial heterogeneity within subgroups of patients not
receiving disability benefits, which could not be explained by our a
priori hypotheses. Possible explanatory factors that we were unable
to explore due to limitations in the reporting of trials include
baseline severity of depression, duration of depression, frequency
of CBT, and experience of CBT providers. Third, none of the
trials evaluated the effect of CBT on return to work (RTW), a
critical outcome for patients receiving disability benefits and for
insurers providing benefits. It remains possible that CBT may
improve BDI–II scores, but may not have any effect on claim
resolution or RTW. Future trials should include these outcomes in
order to ascertain a BDI–II threshold that is associated with RTW
and claim resolution.
Conclusions
If the use of CBT to manage depression among patients
receiving disability benefits was less effective than in patients not
receiving disability benefits, clinicians and payers might reasonably
choose alternative treatment strategies (e.g. pharmacotherapy,
other psychotherapies or a combination of both). The limited
evidence available, however, provides no support for this
hypothesis and suggests that, for the time being, CBT should
continue as a recommended approach for addressing depression in
patients receiving disability benefits. Secure inference will,
however, only be possible after the conduct of much larger
comparative trials, conducted with low risk of bias and in
collaboration with insurers.
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